We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL vial, Novo Nordisk Pharmaceuticals Pty Ltd, CON-324
Product name
FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL vial
Sponsor name
Novo Nordisk Pharmaceuticals Pty Ltd
Consent start
Consent no.
CON-324
Duration
The consent is effective from 15 March 2019 until further notice.
Standard
Subparagraph 10(3)(a)(iii) of the Therapeutic Goods Order No 91 - Standard for labels of prescription and related medicines (TGO 91).
Non-compliance with standard
The primary pack and carton do not express the quantity of each excipient in the
medicine.
Conditions imposed
The products to which this consent applies are those specified in the request
submitted.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines